Cited by 191Hepatocellular Carcinoma Treatment and PrognosisUltrasound and Hyperthermia ApplicationsNanoparticle-Based Drug Delivery

Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite—Initial Experience with Four Patients

Wilson, Mark W., Kerlan, Robert K., Fidelman, Nicholas A., Venook, Alan P., LaBerge, Jeanne M., Koda, Joy, Gordon, Roy L.·2004·Radiology

Abstract

Four patients with inoperable hepatocellular carcinoma were treated with a magnetic targeted carrier bound to doxorubicin (MTC-DOX) by using a joint magnetic resonance (MR) imaging/conventional angiography system consisting of a 1.5-T short-bore magnet connected to a C-arm angiography unit by a sliding tabletop. Selective transcatheter delivery of the MTC-DOX to the hepatic artery was monitored by using intraprocedural MR imaging, and interim catheter manipulation was performed with fluoroscopic guidance to optimize agent delivery to the tumor and minimize delivery to normal tissue. The final fraction of treated tumor volume ranged from 0.64 to 0.91. The fraction of affected normal liver volume ranged from 0.07 to 0.30. The dual MR imaging/conventional angiography system shows promise for directing magnetically targeted tumor therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1148/radiol.2301021493

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Only one magnetically targeted nanocarrier (MTC-DOX) has been evaluated in patients, and it did not produce convincing results, leading to termination of clinical development in phase II/III.

    “From a translational point of view, only one magnetically targeted nanocarrier (which was loaded with doxorubicin; MTC-DOX) has been evaluated in patients, but it did not produce convincing results, leading to termination of clinical development in phase II/III [232, 233].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wilson, M. W., Kerlan, R. K., Fidelman, N. A., Venook, A. P., LaBerge, J. M., Koda, J., & Gordon, R. L.
Affiliations
University of California, San Francisco (US)
Venue
Radiology
Published
2004-01
Volume
230
Issue
1
Pages
287-293
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W2169532237
Cited by
190
References
15
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 7 · 2017: 10 · 2016: 13 · 2015: 10 · 2014: 9 · 2013: 9 · 2012: 9
FWCI
3.57
Type
journal article
Language
en
Open access
closed
Locations
  • Radiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
hepatocellular carcinoma, doxorubicin, hepatic artery, fluoroscopic guidance, tumor targeting, inoperable liver cancer
MeSH terms
Adult, Aged, Angiography, Antibiotics, Antineoplastic, Doxorubicin, Drug Carriers, Equipment Design, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Magnetic Resonance Imaging, Magnetics, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review